Impact of vitamin k antagonists (VKA) on quality of life (QOL) in a prospective cohort of 807 atrial fibrillation (AF) patients

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)132-132
Number of pages1
JournalJOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume13
Publication statusPublished - Jun-2015

Cite this